13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 29 holding rows worth $305,530,000.
- Accession
- 0001696778-21-000004
- Filer
- CIK 1826434
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 31 entries on the cover page, a total value of $305,530,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $305,530,000 with VALUE read as thousands by filing date, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 1,000,000 | $52,610,000 | thousands by filing date | call |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 75,627 | $42,241,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 257,764 | $24,137,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 184,680 | $22,924,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 425,671 | $22,395,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 89,370 | $15,876,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 341,650 | $15,333,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 85,596 | $14,101,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 50,699 | $12,019,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 818,025 | $9,268,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 202,692 | $7,937,000 | thousands by filing date | |
| EVOLUS INC | 30052C107 | COM | 496,826 | $6,285,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 150,783 | $6,155,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 175,305 | $5,862,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 11,305 | $5,005,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 48,267 | $4,999,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 1,048,100 | $4,905,000 | thousands by filing date | call |
| FULGENT GENETICS INC | 359664109 | COM | 50,000 | $4,612,000 | thousands by filing date | call |
| MODERNA INC | 60770K107 | COM | 19,193 | $4,510,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 445,900 | $4,414,000 | thousands by filing date | call |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 94,922 | $4,063,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,253,729 | $3,974,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 269,872 | $2,699,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 313,795 | $2,112,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 6,408 | $1,929,000 | thousands by filing date | |
| CYCLACEL PHARMACE 6percent PFDCONV | 23254L603 | Stock | 313,331 | $1,855,000 | thousands by filing date | |
| FEMASYS INC | 31447E105 | cs | 188,753 | $1,531,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 375,520 | $1,168,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 96,820 | $611,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001696778-21-000004 | this filing | 2021-08-16 | acceptance time not in the bulk data set |